1 |
1.2 mg zgn-440 for injectable suspension |
- |
- |
- |
- |
193 1件: 193 💬 |
2 |
1.8 mg zgn-440 for injectable suspension |
- |
- |
- |
- |
193 1件: 193 💬 |
3 |
[azp-531] |
- |
- |
- |
- |
193 1件: 193 💬 |
4 |
Acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 16件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
5 |
Acomplia |
- |
- |
- |
- |
193 1件: 193 💬 |
6 |
Acomplia 20 mg film-coated tablets |
- |
- |
- |
- |
193 1件: 193 💬 |
7 |
Acth |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 5件: 13, 66, 145, 193, 222 💬 |
8 |
Air |
- |
- |
- |
- |
003 7件: 3 , 51, 58, 85, 97, 193, 299 💬 |
9 |
Anastrozole |
Anastrozole |
1件: D00960 D00960 💬 |
CYP19A1 1件: CYP19A1 💬 |
Metabolic pathways 3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
078 3件: 78, 86, 193 💬 |
10 |
Azp-531 |
- |
- |
- |
- |
193 1件: 193 💬 |
11 |
B. lactis b94 |
- |
- |
- |
- |
193 1件: 193 💬 |
12 |
Beloranib |
Beloranib |
- |
- |
- |
193 1件: 193 💬 |
13 |
Byetta |
- |
- |
- |
- |
006 2件: 6 , 193 💬 |
14 |
Cannabidiol |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 17件: 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
15 |
Cannabidiol oral solution |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
140 4件: 140, 144, 145, 193 💬 |
16 |
Carbetocin |
Carbetocin |
1件: D07229 D07229 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 1件: 193 💬 |
17 |
Cbdv |
Cannabidivarin |
- |
- |
- |
193 1件: 193 💬 |
18 |
Cbdv compound |
Cannabidivarin |
- |
- |
- |
193 1件: 193 💬 |
19 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
20 |
Choline |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 4件: 93, 171, 193, 299 💬 |
21 |
Coenzyme q10 |
Ubidecarenone |
1件: D01065 D01065 💬 |
- |
- |
002 12件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
22 |
D.3.2 product code where applicable13: |
- |
- |
- |
- |
193 1件: 193 💬 |
23 |
Dccr |
- |
- |
- |
- |
193 1件: 193 💬 |
24 |
Diazoxide |
Diazoxide |
1件: D00294 D00294 💬 |
ABCC8 2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
013 2件: 13, 193 💬 |
25 |
Diazoxide choline |
Choline |
2件: D00294 D00294, D07690 D07690 💬 |
ABCC8 2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 1件: 193 💬 |
26 |
Diazoxide choline controlled-release tablet |
Choline |
2件: D00294 D00294, D07690 D07690 💬 |
ABCC8 2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 1件: 193 💬 |
27 |
Eu/1/06/362/003: 5µg (1 pen) |
- |
- |
- |
- |
193 1件: 193 💬 |
28 |
Eutropin |
- |
- |
- |
- |
078 2件: 78, 193 💬 |
29 |
Exenatide |
Exenatide |
1件: D04121 D04121 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 4件: 6 , 17, 193, 233 💬 |
30 |
Fe 992097 |
- |
- |
- |
- |
193 1件: 193 💬 |
31 |
Fluimucil |
- |
- |
- |
- |
085 4件: 85, 94, 193, 298 💬 |
32 |
Fluimucil (acetylcysteine) |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
193 1件: 193 💬 |
33 |
Genotonorm |
- |
- |
- |
- |
193 1件: 193 💬 |
34 |
Genotonorm miniquick 0,2 mg |
- |
- |
- |
- |
193 1件: 193 💬 |
35 |
Genotropin |
- |
- |
- |
- |
013 4件: 13, 78, 187, 193 💬 |
36 |
Genotropin (somatropin) is a growth hormone treatment. it is an exact copy of the natural growth hormone that our bodies make. the main difference is that genotropin is man-made. |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
193 1件: 193 💬 |
37 |
Glwl-01 |
- |
- |
- |
- |
193 1件: 193 💬 |
38 |
Growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 12件: 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
39 |
Growth hormone (genotonorm® or omnitrope®) |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 2件: 78, 193 💬 |
40 |
Guanfacine |
Guanfacine |
2件: D00606 D00606, D08031 D08031 💬 |
ADRA2A 1件: ADRA2A 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
193 1件: 193 💬 |
41 |
Guanfacine extended release (gxr) |
Guanfacine |
2件: D00606 D00606, D08031 D08031 💬 |
ADRA2A 1件: ADRA2A 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
193 1件: 193 💬 |
42 |
Human growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 4件: 78, 187, 193, 265 💬 |
43 |
Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten |
- |
- |
- |
- |
193 1件: 193 💬 |
44 |
Inn not yet proposed |
- |
- |
- |
- |
193 1件: 193 💬 |
45 |
Intranasal carbetocin dose 1 |
Carbetocin |
1件: D07229 D07229 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 1件: 193 💬 |
46 |
Intranasal carbetocin dose 2 |
Carbetocin |
1件: D07229 D07229 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 1件: 193 💬 |
47 |
Intranasal oxytocin |
Oxytocin |
1件: D00089 D00089 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
127 2件: 127, 193 💬 |
48 |
Intranasal oxytocin (in-oxt) |
Oxytocin |
1件: D00089 D00089 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 1件: 193 💬 |
49 |
Liraglutide |
Liraglutide |
1件: D06404 D06404 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 3件: 6 , 75, 193 💬 |
50 |
Livoletide |
Livoletide |
- |
- |
- |
193 1件: 193 💬 |
51 |
Medical air |
Medical air |
- |
- |
- |
085 3件: 85, 86, 193 💬 |
52 |
Medical air vs oxygen |
Medical air |
1件: D00003 D00003 💬 |
- |
- |
193 1件: 193 💬 |
53 |
Metoprolol |
Metoprolol |
3件: D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 6件: 17, 57, 58, 113, 193, 226 💬 |
54 |
Metoprolol succinate |
Metoprolol |
3件: D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 4件: 57, 58, 113, 193 💬 |
55 |
Metoprololsuccinat orion 25mg |
- |
- |
- |
- |
193 1件: 193 💬 |
56 |
Metoprololsuccinat ”orion” 25mg |
- |
- |
- |
- |
193 1件: 193 💬 |
57 |
Metyrapone |
Metyrapone |
2件: D00410 D00410, D05019 D05019 💬 |
CYP11B1 1件: CYP11B1 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
075 2件: 75, 193 💬 |
58 |
Norditropin simplexx |
- |
- |
- |
- |
003 4件: 3 , 78, 193, 195 💬 |
59 |
Nutropin aq |
- |
- |
- |
- |
078 4件: 78, 134, 193, 299 💬 |
60 |
Octreotide |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 7件: 67, 75, 84, 85, 89, 193, 227 💬 |
61 |
Omnitrope |
- |
- |
- |
- |
078 2件: 78, 193 💬 |
62 |
Ot |
- |
- |
- |
- |
193 1件: 193 💬 |
63 |
Other: control |
- |
- |
- |
- |
006 8件: 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
64 |
Other: low dose (1 mcg) acth stimulation test |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
193 1件: 193 💬 |
65 |
Other: overnight metyrapone test |
Metyrapone |
2件: D00410 D00410, D05019 D05019 💬 |
CYP11B1 1件: CYP11B1 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
193 1件: 193 💬 |
66 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
67 |
Oxytocin |
Oxytocin |
1件: D00089 D00089 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
006 5件: 6 , 127, 193, 206, 226 💬 |
68 |
Oxytocin (oxt) continuous |
Oxytocin |
1件: D00089 D00089 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 1件: 193 💬 |
69 |
Physiological serum (sodium chloride) |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
193 1件: 193 💬 |
70 |
Pitolisant |
Pitolisant |
1件: D10749 D10749 💬 |
HRH3 1件: HRH3 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 2件: 6 , 193 💬 |
71 |
Pitolisant oral tablets |
Pitolisant |
1件: D10749 D10749 💬 |
HRH3 1件: HRH3 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
193 1件: 193 💬 |
72 |
Probiotic |
- |
- |
- |
- |
002 7件: 2 , 6 , 93, 96, 97, 193, 266 💬 |
73 |
Procedure: biopsy |
- |
- |
- |
- |
051 3件: 51, 78, 193 💬 |
74 |
Procedure: dexa, blood tests, h.g.p.o, osseous age. |
- |
- |
- |
- |
078 2件: 78, 193 💬 |
75 |
R05cb01 |
- |
- |
- |
- |
193 1件: 193 💬 |
76 |
Recombinant human growth hormon |
- |
- |
- |
- |
193 1件: 193 💬 |
77 |
Recombinant human growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 3件: 78, 193, 265 💬 |
78 |
Recombinant human growth hormone (rhgh) injection |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
193 1件: 193 💬 |
79 |
Recombinant somatropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
193 1件: 193 💬 |
80 |
Rhgh |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
076 4件: 76, 78, 96, 193 💬 |
81 |
Rimonabant |
Rimonabant |
1件: D05731 D05731 💬 |
CNR1 1件: CNR1 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
193 1件: 193 💬 |
82 |
Rm-493 |
- |
- |
- |
- |
193 2件: 193, 202 💬 |
83 |
Sandostatin lar |
- |
- |
- |
- |
067 4件: 67, 84, 193, 227 💬 |
84 |
Saxenda |
- |
- |
- |
- |
193 1件: 193 💬 |
85 |
Sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
86 |
Somatropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 16件: 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
87 |
Subcutaneous beloranib in suspension |
Beloranib |
- |
- |
- |
193 1件: 193 💬 |
88 |
Syntocinon |
- |
- |
- |
- |
006 3件: 6 , 127, 193 💬 |
89 |
Syntocinon nasal spray |
- |
- |
- |
- |
193 1件: 193 💬 |
90 |
Syntocinon®/- spray |
- |
- |
- |
- |
193 1件: 193 💬 |
91 |
Tesofensine |
Tesofensine |
- |
- |
- |
006 2件: 6 , 193 💬 |
92 |
Tesofensine/metoprolol |
Metoprolol |
3件: D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
193 1件: 193 💬 |
93 |
Topiramate |
Topiramate |
1件: D00537 D00537 💬 |
CA2 36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 52件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 5件: 6 , 140, 144, 156, 193 💬 |
94 |
Zgn-440 |
- |
- |
- |
- |
193 1件: 193 💬 |
95 |
Zgn-440 for injectable suspension |
- |
- |
- |
- |
193 1件: 193 💬 |
96 |
Zgn-440 sterile diluent |
- |
- |
- |
- |
193 1件: 193 💬 |